Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00464542 · ClinicalTrials.gov registry record · Phase 4
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
A Phase 4 study of Bacterial Vaginosis, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT00464542 is a Phase 4 study of Bacterial Vaginosis that has completed, run by University of Pittsburgh. The registered enrollment target is 12 participants, below the 337-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00464542, a Phase 4 study of Bacterial Vaginosis, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
This investigation assessed the effects of asymptomatic BV on daily genital tract shedding of HSV-2 by determining shedding frequency before and after treatment of asymptomatic BV.
Conditions Studied
Interventions
- DRUG Metronidazole
Study Locations (2)
Pennsylvania
- University of Pittsburgh - Pittsburgh
- University of Pittsburgh, Magee Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00464542
The ClinicalTrials.gov registry entry for NCT00464542 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 337-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (96% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacterial Vaginosis appearing as the primary indexed condition, and to 1 intervention - of which Metronidazole is the first listed.
NCT00464542 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00464542 about?
NCT00464542 is a clinical study titled "Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study". This investigation assessed the effects of asymptomatic BV on daily genital tract shedding of HSV-2 by determining shedding frequency before and after treatment of asymptomatic BV.
What is the current status of trial NCT00464542?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2007-12. Estimated completion is 2010-03.
What conditions does trial NCT00464542 study?
This clinical trial studies the following conditions: Bacterial Vaginosis.
What interventions are being tested in trial NCT00464542?
The interventions under investigation include: Metronidazole (DRUG).
Who is sponsoring clinical trial NCT00464542?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00464542 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Vaginosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Bacterial Vaginosis (BV) With Tinidazole
COMPLETED · Phase 4
-
Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity
COMPLETED · Phase 4
-
Clinical Protocol CERN Feasibility Study
RECRUITING · NA
-
Prospective Data Bank Creation to Study Vaginal Conditions
RECRUITING
-
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
RECRUITING · Early Phase 1
-
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.